Company Profile
BioCryst Pharmaceuticals Stock Price, News & Analysis
Company overview
Business overview
BioCryst Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, BioCryst Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
BioCryst Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, BioCryst Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
BCRX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
BioCryst's catalysts are Orladeyo execution and sebetralstat progress, plus any rare-disease expansion that widens the HAE story. The business will be judged on whether the orphan-disease base keeps growing.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
BioCryst to Present at Upcoming Investor Conference
Source: BioCryst Pharmaceuticals
- 02
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
Source: BioCryst Pharmaceuticals
- 03
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
Source: BioCryst Pharmaceuticals
- 04
BioCryst to Report First Quarter 2026 Financial Results on May 6
Source: BioCryst Pharmaceuticals
- 05
BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
Source: BioCryst Pharmaceuticals
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.